Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02952729
Title Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mersana Therapeutics
Indications

stomach cancer

lung non-small cell carcinoma

breast adenocarcinoma

Therapies

XMT-1522

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.